ACC Makes Prediction Tool Available to EHRs through Apervita
Tool to connect with patient data to help clinicians predict and prevent atherosclerotic cardiovascular disease (ASCVD)
Chicago, Illinois (February 15, 2016) – Apervita, Inc., the first platform and marketplace for executing and sharing health analytics & data, today announced the American College of Cardiology (ACC) will add a recognized tool for predicting cardiovascular disease to the growing body of analytics being distributed through the Apervita Marketplace.
Published jointly with the American Heart Association, ACC’s ASCVD Risk Estimator is broadly used and respected as a facilitator for physician-patient discussion about risk reduction through lifestyle change. The popular tool has been downloaded more than 250,000 times and is used more than 7,000 times per day by individual providers, but in its current form requires manual transfer of data between records. The goal of the ACC is to make this tool available to every physician dealing with cardiovascular risk. By offering the risk estimator through Apervita, ACC will now make it available from within electronic health records (EHRs) and other systems that physicians use everyday.
"The ACC has been working to give health care providers access to guideline-based tools when they need them at the point of care,” said ACC Chief Information Officer Dino Damalas. “Connecting the ACC's ASCVD Risk Estimator with electronic medical records on this platform will make this decision-support tool more broadly available to busy physicians and other members of the care team around the world.”
A companion tool to the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, the ASCVD Risk Estimator employs multiple algorithms within one analytic to help address 10-year and lifetime risk for ASCVD, defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke.
“We are pleased to have the ASCVD Risk Estimator join the Apervita Marketplace, one more example of analytics from world-class organizations that are already helping clinicians in the delivery of care,” said Paul Magelli, chief executive officer of Apervita. “Clinicians are beginning to be weighed down by today’s growing amount of digital health data, and their time is becoming absorbed in tasks that computers and prediction tools could easily assist them with, providing them the insight they need when they need it. Apervita offers the world’s largest portfolio of executable health analytics from leading enterprises delivered directly into practice. The ACC joins other industry leaders who are using Apervita to distribute and deliver their expertise so it can be put to work globally.”
The American College of Cardiology is a 52,000-member medical society that serves as the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, clinical standards and practice guidelines. The College operates national registries to measure and improve care. It also provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.
Apervita, the fastest growing platform and marketplace for health analytics and data, believes that every health decision should be empowered with the best knowledge. Yet today, most health knowledge is stranded in paper, journals or locked into proprietary, closed systems. Apervita introduces a new platform and marketplace that enables authors of health analytics and data to apply health insight at scale.
Health enterprises use the Apervita platform to transform health knowledge into powerful insight and use it in their workflow. It assists health professionals to deliver better and more efficient care while avoiding the costly pitfalls of deploying analytics and data in silos. With the Apervita platform, enterprises can quickly create, execute, distribute and manage analytics across entire organizations and teams.
With the Apervita marketplace health enterprises can publish and subscribe to health analytics and data from the world-leading institutions. It provides instant access to a catalog of thousands of analytics and data sets at a fraction of today’s cost and time. Leading health brands choose Apervita to commercialize algorithms, measures, pathways, and protocols.